BeStock  

Twist Bioscience TWST

US equityMarket cap rank #1743AI medical concept stocks
$103.32 −$8.30 (-7.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $105.01 +1.64%
Open$108.39
Prev close$111.62
Day range$101.00 – $108.50
Volume3.38M
Market cap$6.85B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.6%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+28.7%
Worst reaction-19.0%

Stock move on the day after each report

+10.0%2024/Q1+28.7%2024/Q2-19.0%2024/Q3+12.3%2024/Q4+0.7%2025/Q1-8.4%2025/Q2-10.3%2025/Q3-10.1%2025/Q4+14.0%2026/Q1-7.0%2026/Q2+10.4%2026/Q3-6.8%2026/Q4
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q412 Nov 2026Pre Market±16.9%-6.83%Within range
2026/Q33 Aug 2026Pre Market±19.2%+10.39%Within range
2026/Q24 May 2026Pre Market±15.3%-6.97%Within range
2026/Q12 Feb 2026Pre Market±17.3%+13.98%Within range
2025/Q414 Nov 2025Pre Market±18.3%-10.13%Within range
2025/Q34 Aug 2025Pre Market±22.9%-10.30%Within range
2025/Q25 May 2025Pre Market±15.2%-8.44%Within range
2025/Q13 Feb 2025Pre Market±17.2%+0.73%Within range
2024/Q418 Nov 2024Pre Market±23.1%+12.31%Within range
2024/Q32 Aug 2024Pre Market±22.4%-19.00%Within range
2024/Q22 May 2024After Market±17.0%+28.74%Bigger than priced
2024/Q12 Feb 2024Pre Market±19.1%+10.01%Within range
2023/Q34 Aug 2023Pre Market±25.5%+11.18%Within range
2023/Q25 May 2023Pre Market±24.4%-0.39%Within range
2023/Q13 Feb 2023Pre Market±17.7%-18.09%Bigger than priced
2022/Q418 Nov 2022Pre Market±28.5%-2.32%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Next-Generation Sequencing (NGS) applications$61.81M 52.2%
  • DNA synthesis and protein solutions$56.57M 47.8%

Latest reported quarter: Q4, ended Sep 2026

Revenue$126.64M+27.9% YoY
Operating profit-$24.41M+18.4% YoY
Net profit-$20.62M+24.0% YoY
Diluted EPS-$0.32+28.9% YoY
Free cash flow-$26.98M-11.3% YoY
Operating cash flow-$173,000.00

Revenue, last 8 quarters

$88.7MDec '24$92.8MMar '25$96.1MJun '25$99.0MSep '25$103.7MDec '25$110.7MMar '26$118.4MJun '26$126.6MSep '26

Net profit, last 8 quarters

$-31.6MDec '24$-39.3MMar '25$20.4MJun '25$-27.1MSep '25$-30.5MDec '25$-44.0MMar '26$-35.1MJun '26$-20.6MSep '26

Profitability & balance sheet

Gross margin52.4%
Operating margin-28.8%
Net margin-28.3%
Return on equity-19.1%
Return on assets-14.8%
Return on invested capital-17.7%
Current ratio5.86
Liabilities / assets20.8%
Cash & investments$581.91M
Total debt$86.54M
Net cash (debt)$495.37M

Discussion

No comments yet — be the first to weigh in on TWST.

Sign in to join the discussion.

Scroll to Top